2013
DOI: 10.1016/j.biomaterials.2012.11.059
|View full text |Cite|
|
Sign up to set email alerts
|

Engineered multilayer ovarian tissue that secretes sex steroids and peptide hormones in response to gonadotropins

Abstract: Although hormone replacement therapy is an option for the loss of ovarian function, hormone delivery through pharmacological means results in various clinical complications. The present study was designed to deliver sex steroids by a functional construct fabricated using encapsulation techniques. Theca and granulosa cells isolated from ovaries of 21-day old rats were encapsulated in multilayer alginate microcapsules to recapitulate the native follicular structure. Cells encapsulated in two other schemes were u… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
30
0
1

Year Published

2013
2013
2022
2022

Publication Types

Select...
5
3

Relationship

1
7

Authors

Journals

citations
Cited by 46 publications
(33 citation statements)
references
References 48 publications
2
30
0
1
Order By: Relevance
“…Several approaches to develop modular ovarian components are under way. Theca and granulosa cells encapsulated in multilayer alginate capsules respond to gonadotropins and secrete sex hormones, which is similar to what occurs in an intact follicle (106). This multilayered engineered ovarian tissue could be applied to treat the loss of ovarian function by providing physiological serum levels of hormones in response to gonadotropins.…”
Section: Emerging Opportunitiesmentioning
confidence: 71%
“…Several approaches to develop modular ovarian components are under way. Theca and granulosa cells encapsulated in multilayer alginate capsules respond to gonadotropins and secrete sex hormones, which is similar to what occurs in an intact follicle (106). This multilayered engineered ovarian tissue could be applied to treat the loss of ovarian function by providing physiological serum levels of hormones in response to gonadotropins.…”
Section: Emerging Opportunitiesmentioning
confidence: 71%
“…This limitation could be overcome with isolating and transplanting less differentiated subpopulation of GCs which has not yet undergone luteinization. On the other side, Sittadjody et al [69] constructed multilayered microcapsule with encapsulated theca cells and GCs from rats to recapitulate the follicular structure. They assessed microcapsules in vitro and demonstrated high viability of encapsulated cells which secreted sex steroids and peptide hormones.…”
Section: Resultsmentioning
confidence: 99%
“…Recently, we demonstrated the importance of the architecture in a tissue engineered ovary through more native-like cell-cell interactions. Through the proper orientation of granulosa and theca cells in an alginate material, more physiologically relevant levels of estrogen and progesterone were produced (Sittadjody et al, 2013).…”
Section: A Overview Of Cells As Therapeutic Delivery Vehiclesmentioning
confidence: 99%